Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United Kingdom

被引：0
|
作者：
Currie, CJ
Dixon, S
Conway, P
McEwan, P
机构：
[1] Cardiff Res Consortium, Cardiff, S Glam, Wales
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] Wyeth UK, Maidenhead, Berks, England
[4] Univ Wales Coll Cardiff, Cardiff, S Glam, Wales
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66147-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：800 / 800
页数：1
相关论文
共 50 条
  • [1] Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
    McEwan, P
    Baboolal, K
    Conway, P
    Currie, CJ
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (11) : 1834 - 1846
  • [2] Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
    Phil McEwan
    Simon Dixon
    Keshwar Baboolal
    Pete Conway
    Craig J. Currie
    [J]. PharmacoEconomics, 2006, 24 : 67 - 79
  • [3] Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
    McEwan, P
    Dixon, S
    Baboolal, K
    Conway, P
    Currie, CJ
    [J]. PHARMACOECONOMICS, 2006, 24 (01) : 67 - 79
  • [4] COMPLIANCE TO TACROLIMUS AND SIROLIMUS IN RENAL TRANSPLANTATION
    Sequeira, C.
    Mota, A.
    Ribeiro, Fontes C. A.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 145 - 145
  • [5] Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
    Formica, RN
    Lorber, KM
    Friedman, AL
    Bia, MJ
    Lakkis, F
    Smith, JD
    Lorber, MI
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 95S - 98S
  • [6] NONCOMPLIANCE TO TACROLIMUS AND SIROLIMUS IN RENAL TRANSPLANTATION
    Sequeira, Clara
    Isabel, Odete
    Mota, Alfredo
    Ribeiro, Carlos Fontes
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 112 - 112
  • [7] Randomized Trial of Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Versus Cyclosporine (Neoral®)/Sirolimus in Renal Transplantation: Seven Year Results.
    Guerra, Giselle
    Gaynor, Jeffrey J.
    Ciancio, Gaetano
    Zarak, Alberto
    Sageshima, Junichiro
    Roth, David
    Kupin, Warren
    Chen, Linda
    Hanson, Lois
    Tueros, Lissett
    Flores, Sandra
    Ruiz, Phillip
    Miller, Joshua
    Burke, George W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 325 - 325
  • [8] Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
    Neylan, JF
    [J]. TRANSPLANTATION, 1998, 65 (04) : 515 - 523
  • [9] Sirolimus Versus Tacrolimus as Primary Immunosuppressant After Renal Transplantation: A Meta-Analysis and Economics Evaluation
    Liu, Jin-yu
    Song, Ming
    Guo, Min
    Huang, Feng
    Ma, Bing-jun
    Zhu, Lan
    Xu, Gang
    Li, Juan
    You, Ru-xu
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1720 - E1728
  • [10] COST-UTILITY ASSESSMENT OF SIROLIMUS VERSUS TACROLIMUS FOR PRIMARY PREVENTION OF GRAFT REJECTION IN RENAL TRANSPLANT RECIPIENTS IN MEXICO
    Rely, K.
    Alexandre, P. K.
    Garcia-Garcia, E. G.
    Mucino-Ortega, E.
    Salinas-escudero, G.
    Galindo-Suarez, R. M.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A156 - A156
12345